Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2011, Article ID 202915, 14 pages
http://dx.doi.org/10.1155/2011/202915
Review Article

Molecular Imaging: A Promising Tool to Monitor Islet Transplantation

Molecular Imaging Laboratory, MGH/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA, 02129, USA

Received 31 May 2011; Accepted 29 July 2011

Academic Editor: Antonello Pileggi

Copyright © 2011 Ping Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. P. Group, “Incidence and trends of childhood type 1 diabetes worldwide 1990–1999,” Diabetic Medicine, vol. 23, no. 8, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Azzi, A. S. Geara, S. El-Sayegh, and R. Abdi, “Immunological aspects of pancreatic islet cell transplantation,” Expert Review of Clinical Immunology, vol. 6, no. 1, pp. 111–124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. W. D. Kelly, R. C. Lillehei, F. K. Merkel, Y. Idezuki, and F. G. Goetz, “Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy,” Surgery, vol. 61, no. 6, pp. 827–837, 1967. View at Google Scholar · View at Scopus
  4. P. Fioretto, M. W. Steffes, D. E. R. Sutherland, F. C. Goetz, and M. Mauer, “Reversal of lesions of diabetic nephropathy after pancreas transplantation,” The New England Journal of Medicine, vol. 339, no. 2, pp. 69–75, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Downing, “Historical review of pancreatic islet transplantation,” World Journal of Surgery, vol. 8, no. 2, pp. 137–142, 1984. View at Google Scholar · View at Scopus
  6. P. E. Lacy and M. Kostianovsky, “Method for the isolation of intact islets of Langerhans from the rat pancreas,” Diabetes, vol. 16, no. 1, pp. 35–39, 1967. View at Google Scholar · View at Scopus
  7. P. J. Hauptman and K. J. O'Connor, “Procurement and allocation of solid organs for transplantation,” The New England Journal of Medicine, vol. 336, no. 6, pp. 422–431, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. P. G. Stock and J. A. Bluestone, “Beta-cell replacement for type I diabetes,” Annual Review of Medicine, vol. 55, pp. 133–156, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. R. G. Bretzel, D. Brandhorst, H. Brandhorst et al., “Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management,” Journal of Molecular Medicine, vol. 77, no. 1, pp. 140–143, 1999. View at Google Scholar · View at Scopus
  10. A. M. J. Shapiro, J. R. T. Lakey, E. A. Ryan et al., “Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen,” The New England Journal of Medicine, vol. 343, no. 4, pp. 230–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Alejandro, F. B. Barton, B. J. Hering, and S. Wease, “2008 update from the collaborative islet transplant registry,” Transplantation, vol. 86, no. 12, pp. 1783–1788, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. J. Shapiro, C. Ricordi, B. J. Hering et al., “International trial of the Edmonton protocol for islet transplantation,” The New England Journal of Medicine, vol. 355, no. 13, pp. 1318–1330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. E. A. Ryan, B. W. Paty, P. A. Senior et al., “Five-year follow-up after clinical islet transplantation,” Diabetes, vol. 54, no. 7, pp. 2060–2069, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. N. R. Barshes, S. Wyllie, and J. A. Goss, “Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts,” Journal of Leukocyte Biology, vol. 77, no. 5, pp. 587–597, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Lacotte, T. Berney, A. J. Shapiro, and C. Toso, “Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events,” Expert Opinion on Biological Therapy, vol. 11, no. 1, pp. 55–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. D. Stegall, K. J. Lafferty, I. Sam, and R. G. Gill, “Evidence of recurrent autoimmunity in human allogeneic islet transplantation,” Transplantation, vol. 61, no. 8, pp. 1272–1274, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Jaeger, B. J. Hering, E. Hatziagelaki, K. Federlin, and R. G. Bretzel, “Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression,” Journal of Molecular Medicine, vol. 77, no. 1, pp. 45–48, 1999. View at Google Scholar · View at Scopus
  18. N. Niclauss, D. Bosco, P. Morel, L. Giovannoni, T. Berney, and G. Parnaud, “Rapamycin impairs proliferation of transplanted islet β cells,” Transplantation, vol. 91, no. 7, pp. 714–722, 2011. View at Publisher · View at Google Scholar
  19. E. A. Ryan, J. R. T. Lakey, R. V. Rajotte et al., “Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol,” Diabetes, vol. 50, no. 4, pp. 710–719, 2001. View at Google Scholar · View at Scopus
  20. A. Pileggi, C. Ricordi, M. Alessiani, and L. Inverardi, “Factors influencing islet of Langerhans graft function and monitoring,” Clinica Chimica Acta, vol. 310, no. 1, pp. 3–16, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Castano and G. S. Eisenbarth, “Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat,” Annual Review of Immunology, vol. 8, pp. 647–679, 1990. View at Google Scholar · View at Scopus
  22. M. A. Atkinson and N. K. Maclaren, “Mechanisms of disease: the pathogenesis of insulin-dependent diabetes mellitus,” The New England Journal of Medicine, vol. 331, no. 21, pp. 1428–1436, 1994. View at Publisher · View at Google Scholar · View at Scopus
  23. T. F. Massoud and S. S. Gambhir, “Molecular imaging in living subjects: seeing fundamental biological processes in a new light,” Genes and Development, vol. 17, no. 5, pp. 545–580, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Gotthardt, “A therapeutic insight in β-cell imaging?” Diabetes, vol. 60, no. 2, pp. 381–382, 2011. View at Publisher · View at Google Scholar
  25. A. Moore, Z. Medarova, P. Vallabhajosyula et al., “In vivo imaging of autologous islet grafts in the liver and under the kidney capsule in non-human primates,” Transplantation, vol. 87, no. 11, pp. 1659–1666, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Hara, X. Wang, T. Kawamura et al., “Transgenic mice with green fluorescent protein-labeled pancreatic β-cells,” American Journal of Physiology—Endocrinology and Metabolism, vol. 284, no. 1, pp. E177–E183, 2003. View at Google Scholar
  27. Z. Medarova, S. Bonner-Weir, M. Lipes, and A. Moore, “Imaging β-cell death with a near-infrared probe,” Diabetes, vol. 54, no. 6, pp. 1780–1788, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Ran, P. Pantazopoulos, Z. Medarova, and A. Moore, “Synthesis and testing of beta-cell-specific streptozotoein-derived near-infrared imaging probes,” Angewandte Chemie—International Edition, vol. 46, no. 47, pp. 8998–9001, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Reiner, R. H. Kohler, C. W. Liew et al., “Near-infrared fluorescent probe for imaging of pancreatic β cells,” Bioconjugate Chemistry, vol. 21, no. 7, pp. 1362–1368, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Virostko, A. Radhika, G. Poffenberger et al., “Bioluminescence imaging in mouse models quantifies β cell mass in the pancreas and after islet transplantation,” Molecular Imaging and Biology, vol. 12, no. 1, pp. 42–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Moore, S. Bonner-Weir, and R. Weissleder, “Noninvasive in vivo measurement of β-cell mass in mouse model of diabetes,” Diabetes, vol. 50, no. 10, pp. 2231–2236, 2001. View at Google Scholar · View at Scopus
  32. L. Ladriěre, F. Malaisse-Lagae, R. Alejandro, and W. J. Malaisse, “Pancreatic fate of a 125I-labelled mouse monoclonal antibody directed against pancreatic B-cell surface ganglioside(s) in control and diabetic rats,” Cell Biochemistry and Function, vol. 19, no. 2, pp. 107–115, 2001. View at Publisher · View at Google Scholar
  33. K. N. Samli, M. J. McGuire, C. B. Newgard, S. A. Johnston, and K. C. Brown, “Peptide-mediated targeting of the islets of Langerhans,” Diabetes, vol. 54, no. 7, pp. 2103–2108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. C. S. Hampe, A. R. Wallen, M. Schlosser, M. Ziegler, and I. R. Sweet, “Quantitative evaluation of a monoclonal antibody and its fragment as potential markers for pancreatic beta cell mass,” Experimental and Clinical Endocrinology and Diabetes, vol. 113, no. 7, pp. 381–387, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Ueberberg, J. J. Meier, C. Waengler et al., “Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic β- or α-cells in vivo,” Diabetes, vol. 58, no. 10, pp. 2324–2334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Anlauf, R. Eissele, M. K.-H. Schäfer et al., “Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors,” Journal of Histochemistry and Cytochemistry, vol. 51, no. 8, pp. 1027–1040, 2003. View at Google Scholar
  37. D. J. Pettibone, J. A. Totaro, and A. B. Pflueger, “Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants,” European Journal of Pharmacology, vol. 102, no. 3-4, pp. 425–430, 1984. View at Google Scholar · View at Scopus
  38. M. Freeby, R. Goland, M. Ichise, A. Maffei, R. Leibel, and P. E. Harris, “VMAT2 quantitation by PET as a biomarker for β-cell mass in health and disease,” Diabetes, Obesity and Metabolism, vol. 10, supplement 4, pp. 98–108, 2008. View at Publisher · View at Google Scholar
  39. L. Zhu, J. Liu, and H. F. Kung, “Synthesis and evaluation of 2-amino-dihydrotetrabenzine derivatives as probes for imaging vesicular monoamine transporter-2,” Bioorganic and Medicinal Chemistry Letters, vol. 19, no. 17, pp. 5026–5028, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. M. P. Kung, C. Hou, B. P. Lieberman et al., “In vivo imaging of β-cell mass in rats using 18F-FP-(+)- DTBZ: a potential PET ligand for studying diabetes mellitus,” Journal of Nuclear Medicine, vol. 49, no. 7, pp. 1171–1176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Eng, W. A. Kleinman, L. Singh, G. Singh, and J. P. Raufman, “Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas,” Journal of Biological Chemistry, vol. 267, no. 11, pp. 7402–7405, 1992. View at Google Scholar · View at Scopus
  42. M. Gotthardt, M. Fischer, I. Naeher et al., “Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 29, no. 5, pp. 597–606, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Brom, K. Andraojć, W. J. G. Oyen, O. C. Boerman, and M. Gotthardt, “Development of radiotracers for the determination of the beta-cell mass in vivo,” Current Pharmaceutical Design, vol. 16, no. 14, pp. 1561–1567, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Pattou, J. Kerr-Conte, and D. Wild, “GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle,” The New England Journal of Medicine, vol. 363, no. 13, pp. 1289–1290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Ladriere, F. Malaisse-Lagae, and W. J. Malaisse, “Uptake of tritiated glibenclamide by endocrine and exocrine pancreas,” Endocrine, vol. 13, no. 1, pp. 133–136, 2000. View at Google Scholar · View at Scopus
  46. A. Schmitz, C. Y. Shiue, Q. Feng et al., “Synthesis and evaluation of fluorine-18 labeled glyburide analogs as β-cell imaging agents,” Nuclear Medicine and Biology, vol. 31, no. 4, pp. 483–491, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Schneider, P. J. Feilen, M. Schreckenberger et al., “In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans,” Experimental and Clinical Endocrinology and Diabetes, vol. 113, no. 7, pp. 388–395, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. I. R. Sweet, D. L. Cook, Å. Lernmark et al., “Systematic screening of potential β-cell imaging agents,” Biochemical and Biophysical Research Communications, vol. 314, no. 4, pp. 976–983, 2004. View at Publisher · View at Google Scholar
  49. L. Ladrière, V. Leclercq-Meyer, and W. J. Malaisse, “Assessment of islet β-cell mass in isolated rat pancreases perfused with D-[3H]mannoheptulose,” American Journal of Physiology—Endocrinology and Metabolism, vol. 281, no. 2, pp. E298–E303, 2001. View at Google Scholar
  50. W. J. Malaisse and L. Ladrière, “Assessment of B-cell mass in isolated islets exposed to D-[3H]mannoheptulose,” International Journal of Molecular Medicine, vol. 7, no. 4, pp. 405–406, 2001. View at Google Scholar · View at Scopus
  51. W. J. Malaisse, M. Doherty, M. M. Kadiata, L. Ladriere, and F. Malaisse-Lagae, “Pancreatic fate of D-[3H] mannoheptulose,” Cell Biochemistry and Function, vol. 19, no. 3, pp. 171–179, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. Q. Zheng, H. Dai, M. Merritt et al., “Magnetic relaxation agents for cell labeling and imaging applications,” in Imaging the Pancreatic Beta Cell, Bethesda, Md, USA, 2003. View at Google Scholar
  53. A. Sambanis, C. Stabler, S. Tang et al., “Development and non-invasive monitoring of a pancreatic tissue substitute,” in Imaging the Pancreatic Beta Cell, Bethesda, Md, USA, 2003. View at Google Scholar
  54. I. Constantinidis, J. R. R. Long, C. Weber, S. Safley, and A. Sambanisb, “Non-invasive monitoring of a bioartificial pancreas in vitro and in vivo,” Annals of the New York Academy of Sciences, vol. 944, pp. 83–96, 2001. View at Google Scholar · View at Scopus
  55. D. Lu, H. Mulder, P. Zhao et al., “13C NMR isotopomer analysis reveals a connection between pyruvate cycling and glucose-stimulated insulin secretion (GSIS),” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 5, pp. 2708–2713, 2002. View at Publisher · View at Google Scholar · View at Scopus
  56. B. Gimi, L. Leoni, S. Eroglu et al., “Imaging of pancreatic beta-cell function by Mn2+-enhanced MRI,” in Imaging the Pancreatic Beta Cell, Bethesda, Md, USA, 2003. View at Google Scholar
  57. B. Gimi, L. Leoni, J. Oberholzer et al., “Functional MR microimaging of pancreatic β-cell activation,” Cell Transplantation, vol. 15, no. 2, pp. 195–203, 2006. View at Publisher · View at Google Scholar · View at Scopus
  58. P. F. Antkowiak, S. A. Tersey, J. D. Carter et al., “Noninvasive assessment of pancreatic β-cell function in vivo with manganese-enhanced magnetic resonance imaging,” American Journal of Physiology—Endocrinology and Metabolism, vol. 296, no. 3, pp. E573–E578, 2009. View at Publisher · View at Google Scholar
  59. J. Yong, J. Rasooly, H. Dang et al., “Multimodality imaging of β-cells in mouse models of type 1 and 2 diabetes,” Diabetes, vol. 60, no. 5, pp. 1383–1392, 2011. View at Publisher · View at Google Scholar
  60. D. Kaufman, M. Baker, J. Nelson et al., “In vivo, real-time, non-invasive bioluminescent imaging of transplanted islets in a functional murine model,” in Imaging the Pancreatic Beta Cell, Bethesda, Md, USA, 2003. View at Google Scholar
  61. A. Powers, M. Fowler, J. Virostko et al., “Using bioluminescence to non-invasively image and assess transplanted islet mass,” in Imaging the Pancreatic Beta Cell, Bethesda, Md, USA, 2003. View at Google Scholar
  62. Y. Lu, H. Dang, B. Middleton et al., “Bioluminescent monitoring of islet graft survival after transplantation,” Molecular Therapy, vol. 9, no. 3, pp. 428–435, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Fowler, J. Virostko, Z. Chen et al., “Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging,” Transplantation, vol. 79, no. 7, pp. 768–776, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. A. Cao, M. H. Bachmann, A. Beilhack et al., “Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation,” Transplantation, vol. 80, no. 1, pp. 134–139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  65. X. Chen, X. Zhang, C. S. Larson, M. S. Baker, and D. B. Kaufman, “In vivo bioluminescence imaging of transplanted islets and early detection of graft rejection,” Transplantation, vol. 81, no. 10, pp. 1421–1427, 2006. View at Publisher · View at Google Scholar · View at Scopus
  66. S. Bertera, X. Geng, Z. Tawadrous et al., “Body window-enabled in vivo multicolor imaging of transplanted mouse islets expressing an insulin-timer fusion protein,” BioTechniques, vol. 35, no. 4, pp. 718–722, 2003. View at Google Scholar · View at Scopus
  67. N. V. Evgenov, Z. Medarova, G. Dai, S. Bonner-Weir, and A. Moore, “In vivo imaging of islet transplantation,” Nature Medicine, vol. 12, no. 1, pp. 144–148, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. O. Eriksson, T. Eich, A. Sundin et al., “Positron emission tomography in clinical islet transplantation,” American Journal of Transplantation, vol. 9, no. 12, pp. 2816–2824, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. Y. Lu, H. Dang, B. Middleton et al., “Repetitive microPET imaging of implanted human islets in mice,” in Imaging the Pancreatic Beta Cell, Bethesda, Md, USA, 2003. View at Google Scholar
  70. Y. Lu, H. Dang, B. Middleton et al., “Long-term monitoring of transplanted islets using positron emission tomography,” Molecular Therapy, vol. 14, no. 6, pp. 851–856, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. S. J. Kim, D. J. Doudet, A. R. Studenov et al., “Quantitative micro positron emission tomography (PET) imaging for the in vivo determination of pancreatic islet graft survival,” Nature Medicine, vol. 12, no. 12, pp. 1423–1428, 2006. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Toso, H. Zaidi, P. Morel et al., “Positron-emission tomography imaging of early events after transplantation of islets of Langerhans,” Transplantation, vol. 79, no. 3, pp. 353–355, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. T. Eich, O. Eriksson, A. Sundin et al., “Positron emission tomography: a real-time tool to quantify early islet engraftment in a preclinical large animal model,” Transplantation, vol. 84, no. 7, pp. 893–898, 2007. View at Publisher · View at Google Scholar · View at Scopus
  74. T. Eich, O. Eriksson, and T. Lundgren, “Visualization of early engraftment in clinical islet transplantation by positron-emission tomography,” The New England Journal of Medicine, vol. 356, no. 26, pp. 2754–2755, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. T. Shen, R. Weissleder, M. Papisov, A. Bogdanov, and T. J. Brady, “Monocrystalline iron oxide nanocompounds (MION): physicochemical properties,” Magnetic Resonance in Medicine, vol. 29, no. 5, pp. 599–604, 1993. View at Google Scholar · View at Scopus
  76. D. Jirák, J. Kríz, V. Herynek et al., “MRI of transplanted pancreatic islets,” Magnetic Resonance in Medicine, vol. 52, no. 6, pp. 1228–1233, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. L. Biancone, S. G. Crich, V. Cantaluppi et al., “Magnetic resonance imaging of gadolinium-labeled pancreatic islets for experimental transplantation,” NMR in Biomedicine, vol. 20, no. 1, pp. 40–48, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. N. V. Evgenov, Z. Medarova, J. Pratt et al., “In vivo imaging of immune rejection in transplanted pancreatic islets,” Diabetes, vol. 55, no. 9, pp. 2419–2428, 2006. View at Publisher · View at Google Scholar · View at Scopus
  79. T. Koblas, P. Girman, Z. Berkova et al., “Magnetic resonance imaging of intrahepatically transplanted islets using paramagnetic beads,” Transplantation Proceedings, vol. 37, no. 8, pp. 3493–3495, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. H. T. Joo, P. Foster, A. Rosales et al., “Imaging islets labeled with magnetic nanoparticles at 1.5 Tesla,” Diabetes, vol. 55, no. 11, pp. 2931–2938, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. B. P. Barnett, A. Arepally, P. V. Karmarkar et al., “Magnetic resonance-guided, real-time targeted delivery and imaging of magnetocapsules immunoprotecting pancreatic islet cells,” Nature Medicine, vol. 13, no. 8, pp. 986–991, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. C. Toso, J. P. Vallee, P. Morel et al., “Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling,” American Journal of Transplantation, vol. 8, no. 3, pp. 701–706, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. Z. Fan, J. A. Spencer, Y. Lu et al., “In vivo tracking of ‘color-coded’ effector, natural and induced regulatory T cells in the allograft response,” Nature Medicine, vol. 16, no. 6, pp. 718–722, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. C. Ricordi and T. B. Strom, “Clinical islet transplantation: advances and immunological challenges,” Nature Reviews Immunology, vol. 4, no. 4, pp. 259–268, 2004. View at Google Scholar · View at Scopus
  85. X. Chen, X. Zhang, C. Larson, F. Chen, H. Kissler, and D. B. Kaufman, “The epididymal fat pad as a transplant site for minimal islet mass,” Transplantation, vol. 84, no. 1, pp. 122–125, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. S. Speier, D. Nyqvist, O. Cabrera et al., “Noninvasive in vivo imaging of pancreatic islet cell biology,” Nature Medicine, vol. 14, no. 5, pp. 574–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Speier, D. Nyqvist, M. Köhler, A. Caicedo, I. B. Leibiger, and P. O. Berggren, “Noninvasive high-resolution in vivo imaging of cell biology in the anterior chamber of the mouse eye,” Nature Protocols, vol. 3, no. 8, pp. 1278–1286, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. M. H. Abdulreda, G. Faleo, R. D. Molano et al., “High-resolution, noninvasive longitudinal live imaging of immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 31, pp. 12863–12868, 2011. View at Google Scholar
  89. D. J. Roth, E. D. Jansen, A. C. Powers, and T. G. Wang, “A novel method of monitoring response to islet transplantation: bioluminescent imaging of an NF-kB transgenic mouse model,” Transplantation, vol. 81, no. 8, pp. 1185–1190, 2006. View at Publisher · View at Google Scholar · View at Scopus
  90. X. Chen, X. Zhang, C. Larson, G. Xia, and D. B. Kaufman, “Prolonging islet allograft survival using in vivo bioluminescence imaging to guide timing of antilymphocyte serum treatment of rejection,” Transplantation, vol. 85, no. 9, pp. 1246–1252, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. P. Wang, M. V. Yigit, Z. Medarova et al., “Combined small interfering RNA therapy and in vivo magnetic resonance imaging in islet transplantation,” Diabetes, vol. 60, no. 2, pp. 565–571, 2011. View at Publisher · View at Google Scholar
  92. Z. Medarova, M. Kumar, S. W. Ng et al., “Multifunctional magnetic nanocarriers for image-tagged SiRNA delivery to intact pancreatic islets,” Transplantation, vol. 86, no. 9, pp. 1170–1177, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. S. P. Raikwar and N. Zavazava, “Spontaneous in vivo differentiation of embryonic stem cell-derived pancreatic endoderm-like cells corrects hyperglycemia in diabetic mice,” Transplantation, vol. 91, no. 1, pp. 11–20, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. B. P. Barnett, J. Ruiz-Cabello, P. Hota et al., “Fluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imaging,” Radiology, vol. 258, no. 1, pp. 182–191, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. N. V. Evgenov, J. Pratt, P. Pantazopoulos, and A. Moore, “Effects of glucose toxicity and islet purity on in vivo magnetic resonance imaging of transplanted pancreatic islets,” Transplantation, vol. 85, no. 8, pp. 1091–1098, 2008. View at Publisher · View at Google Scholar · View at Scopus
  96. A. M. Davalli, L. Scaglia, D. H. Zangen, J. Hollister, S. Bonner-Weir, and G. C. Weir, “Vulnerability of islets in the immediate posttransplantation period: dynamic changes in structure and function,” Diabetes, vol. 45, no. 9, pp. 1161–1167, 1996. View at Google Scholar · View at Scopus
  97. M. Biarnés, M. Montolio, V. Nacher, M. Raurell, J. Soler, and E. Montanya, “β-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia,” Diabetes, vol. 51, no. 1, pp. 66–72, 2002. View at Google Scholar · View at Scopus
  98. E. Montana, S. Bonner-Weir, and G. C. Weir, “Beta cell mass and growth after syngeneic islet cell transplantation in normal and streptozocin diabetic C57BL/6 mice,” Journal of Clinical Investigation, vol. 91, no. 3, pp. 780–787, 1993. View at Google Scholar · View at Scopus
  99. L. Makhlouf, V. F. Duvivier-Kali, S. Bonner-Weir, H. Dieperink, G. C. Weir, and M. H. Sayegh, “Importance of hyperglycemia on the primary function of allogeneic islet transplants,” Transplantation, vol. 76, no. 4, pp. 657–664, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. V. Nacher, J. F. Merino, M. Raurell, J. Soler, and E. Montanya, “Normoglycemia restores β-cell replicative response to glucose in transplanted islets exposed to chronic hyperglycemia,” Diabetes, vol. 47, no. 2, pp. 192–196, 1998. View at Google Scholar · View at Scopus
  101. R. Melzi, M. Battaglia, E. Draghici, E. Bonifacio, and L. Piemonti, “Relevance of hyperglycemia on the timing of functional loss of allogeneic islet transplants: implication for mouse model,” Transplantation, vol. 83, no. 2, pp. 167–173, 2007. View at Publisher · View at Google Scholar · View at Scopus
  102. D. L. Eizirik, L. Jansson, M. Flodström, C. Hellerström, and A. Andersson, “Mechanisms of defective glucose-induced insulin release in human pancreatic islets transplanted to diabetic nude mice,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 8, pp. 2660–2663, 1997. View at Publisher · View at Google Scholar
  103. L. Jansson, D. L. Elzirik, D. G. Pipeleers, L. A. H. Borg, C. Hellerstrom, and A. Andersson, “Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice,” Journal of Clinical Investigation, vol. 96, no. 2, pp. 721–726, 1995. View at Google Scholar
  104. S. P. Raikwar and N. Zavazava, “Real-time non-invasive imaging of ES cell-derived insulin producing cells,” Methods in Molecular Biology, vol. 590, pp. 317–334, 2009. View at Google Scholar · View at Scopus